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Incorporation of 2-deoxy-o-galactose into the oligosaccharide moieties of different gangliosides of rat liver was examined. After intraperitoneal 
administration of 2-deoxy-n-galactose it was shown by GLC/MS analysis that this hexose analogue is metabolized and incorporated into all the 
ganghosides investigated. and predommantly mto G,, and G,,. In both of these gangliosides. 25-55% of the galactose residues were substituted 
by 2-deoxy-n-galactose. The epimer, 2-deoxy-n-glucose, was not detectable. 
Ganglioside; 2-Deoxy-o-galactose: Hexose analogue 
1. INTRODUCTION 
In an earlier study, it was demonstrated that the D- 
galactose analogue, 2-deoxy-D-galactose (2dGal), is me- 
tabolized by the same pathway as the naturally occur- 
ring hexose D-galactose in rat liver [l]. The main meta- 
bolites were 2-deoxy-p-galactose- 1 -phosphate (99.3%) 
UDP-2-deoxy-D-galactose (0.3%) and, after epimeriza- 
tion, UDP-2-deoxy-D-glucose (0.1%). These results sug- 
gested that the UDP-hexode analogues may act as sub- 
strates for the respective glycosyltransferases involved 
in the biosynthesis of glycoconjugates. In an earlier 
study, we presented the first evidence that this assump- 
tion is true for glycoproteins [2]. Recently, using GLCI 
MS analysis, we demonstrated that 2dGal is incorpo- 
rated into the oligosaccharide moiety of membrane 
glycoproteins of HepG2 cells. The incorporation of 
2dGal was paralleled by a reduced al-2 fucosylation [3]. 
In the present study, we investigated the incorpora- 
tion of 2dGal into the oligosaccharide moiety of glyco- 
sphingolipids (GSLs) of rat liver. GSL biosynthesis in 
rat liver is well documented [4-91. Recently, it was sug- 
gested that the first steps of GSL biosynthesis occur on 
the cytoplasmic leaflet of the Golgi apparatus. Evidence 
was provided that UDP-Glc:Cer /?-1 glucosyltrans- 
ferase and UDP-Gal:Glc-Cer /I14 galactosyltrans- 
Correspondence address: CC. Geilen, Haut- und Poliklimk, 
Universitats-klimkum Steglitz, Freie Universitat Berlin, D-1000 Berlin 
45 (Dahlem), Germany. Fax: (49) (30) 798-4141. 
Abbrevzatiow Gangliosides are coded according to the nomenclature 
of Svennerholm [13] and the IUPAC-IUB recommendations [14]; 
GSL, glycosphingohpid; ZdGal, 2-deoxy-o-galactose; GLC/MS, gas- 
hquid chromatography/mass spectrometry; FAB/MS, fast atom bom- 
bardment/mass spectrometry; EL electric ionization. 
ferase are located on the cytoplasmic side of the Golgi 
apparatus, whereas enzymes catalysing subsequent 
steps occur at the luminal side [lo]. These results have 
been confirmed by Pagan0 and co-workers [l 11, but 
there are also studies which located the biosynthesis of 
lactosylceramide in the Golgi lumen [12]. If the first 
steps of GSL biosynthesis have a cytoplasmic location, 
UDP-2dGal does not need to be specially transported 
into the Golgi apparatus in order to serve as a substrate. 
The present study describes the isolation and structural 
characterization of modified gangliosides occurring in 
rat liver after treatment of rats with 2dGal. Our data 
show for the first time that 2dGal is incorporated into 
G,,, Go,, Go,, and G,,,. The incorporation of 2dGal 
into gangliosides was higher as compared to the incor- 
poration of 2dGal into glycoproteins [3]. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
All solvents for GLC were purchased from Promochem (Wesel, 
Germany) in GLC quality. 2-Deoxy-o-galactose and n-galactose were 
purchased from Sigma (Mdnchen). Acetonitrile HPLC Grade E was 
purchased from Rathburn chemicals Ltd. (Scotland, UK), other sol- 
vents from Roth (Karlsruhe, Germany) in p.a. grade. Sephadex G 25 
was from Pharmacia (Sweden), sodium borohydride from Serva (Hei- 
delberg, Germany). Standard bovine brain gangliostdes were from 
BioCarb (Sweden). Other chemicals were from Merck (Darmstadt, 
Germany) and of p.a. grade. 
2.2. Treatment of ammals 
Male Buffalo rats with an average body weight between 350 and 400 
g were intraperitoneally injected twice a day with 2dGal at a concen- 
tratton of 200 mg per kg body weight for 8 days. Livers were perfused 
during narcosis, removed and stored at -20°C. 
2.3. Extractzon and purlficatlon of glycosphingoliprds (GSLs) 
All steps were carried out at 4°C. Samples of rat liver were homog- 
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enized in distilled water, centrifuged at 70.000 x g and the pellets 
washed twice by suspension in distilled water and centrifugation. The 
pellets were then lyophihzed to dryness. Total lipids were extracted 
according to the method Ribom et al. [15]. Neutral GSL and 
phosphohpids were removed by partition in diisopropylether/n-bu- 
tanoll50 mM aqueous NaCl (6:4:5. by vol.) according to the method 
of Ladisch et al. [16]. The aqueous phase was evaporated to dryness 
To remove remaining glycerophospholipids the lipid extract was incu- 
bated with 0.2 M methanolic NaOH at 37°C for 1 h. After neutrahza- 
lion with 0.2 M acetic acid in methanol, the mixtures were extracted 
with 10 ml n-hexane per g liver wet weight. The samples were desalted 
by Sephadex G-25 column chromatography Briefly, samples were 
dissolved m chloroform/methanol/water (60.30.4.5; by vol.) and ap- 
plied to a Sephadex G-25 column prewashed with the same eluent. 
GSLs were eluted with chloroform/methanol (2:l. v/v) and chloro- 
form/methanol/water (60:30:4.5; by vol.) [17]. Eluates were pooled and 
evaporated to dryness. Remaining neutral GSLs and sphingomyelin 
were removed by silica gel chromatography. The samples were ad- 
sorbed on a silica gel column and washed thoroughly with ether. 
Gangliosides were then eluted with chloroform/methanol (2:l and 1.4: 
v/v). Eluates were pooled and dried under vacua 
2.4. HPLC and HPTLCproceduresfor analysis anddetection ojCSLs 
The HPLC system consisted of two pumps (Bischoff Analysentech- 
nik, Leonberg, Germany), a programmer (Kontron Analytik. 
Miinchen). an UV-detector (SPDdAV. Shimadzu. Japan), an injec- 
tion valve (Model 7125, Rheodyne Incorp. USA) and a fraction collec- 
tor (221 I Superrac. LKB, Sweden). Chromatography was performed 
according to Gazzotti et al. [18] with slight modifications: two series- 
connected Spherisorb-NH:-columns (2 x 250 x 4 6 mm, particle size 
5 pm; Knauer Saulen-technik, Germany) were used and the time of 
the gradient was extended to 150 min. 
HPTLC was performed on pre-coated high-performance thin-layer 
plates (Silica Gel 60 for nano-DC; Merck. Germany) Gangliosides 
were developed m chloroform/methanol/0.2% aqueous CaCI, 
(50:45:10; by vol.), and visualized by stammg with copper sulfate/ 
phosphoric acid reagent (10% CuSO,in 8.5% phosphoric acid) accord- 
mg to Touchstone et al. [19]. 
2.5. Preparation of JampIes for GLC 
To ascertam the rate of exchanged galactose residues, the same 
amounts of isolated gangliosides were hydrolysed under two different 
conditions: for complete release of galactose of the gangliosides, sam- 
ples were hydrolysed by heating in 2 M HCI at 100°C for 3 h. Since 
2dGal is degraded under these conditions. in a second procedure 
hydrolysation was performed with 62 5 mmol/l HSO, as described by 
Schmidt et al. [20]. Under this condition 2dGal is conserved and could 
be obtained nearly completely, but only about 10% of the other mon- 
osaccharides could be released. From this determination the content 
of 2dGal could be calculated, whereas the content of o-galactose is 
calculated under the conditions described first. 
Samples were placed on a Dowex AG 3 x 4 column (acetic form, 
Bio-Rad. Mdnchen, Germany). After elution with double-distilled 
water, the sample was evaporated to dryness, and monosaccharides 
were reduced with 2% sodium borohydride (Serva. Germany) m bo- 
rate buffer. pH 9.1. Acetylation was performed as described by Geyer 
et al. [21] with slight modifications. Standard monosaccharides were 
reduced and acetylated as described above. 
2.6 Caprllary gas liqutd chromatography mass spectrometry (GLCI 
For quantitative analysis a Carlo Erba HRCG 5300 gas chromato- 
graph, equipped with flame ionisation detection (FID), was used as 
described earlier [3]. Samples were analysed on a DB210-30N capillary 
column (J&W Scientific, Ranch0 Cordova, USA) by on-column injec- 
tion and on a DBl-60N capillary column (J&W Scientific, Ranch0 
Cordova. USA) using a moving needle injection system (Chrompack. 
Miillheim, Germany). Hydrogen served as the carrier gas. The temper- 
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ature program ws from 50°C to 100°C at 40”Clmm. then raised to 
240°C at 3”C/min. 
A Perkin Elmer 8420 gas chromatograph coupled with a Perkm 
Elmer Ion Trap Detector (ITD) was used for GLC/MS analysis Sam- 
ples were analysed on a DBl-60N capillary column (J&W Scientific, 
Ranch0 Cordova, USA) by on-column InJection. Helium served as the 
carrier gas. The temperature program was from 50°C to 150°C at 
30”C/min, then to 250°C at 2 8”C/min. 
Peaks were identified by then retention times relative to that of 
inositol as Internal standard, and by their correspondmg mass spectra 
[23,23]. 
2.7. Fast atom bombardment mass spectrometry (FABIMS] 
FAB/MS was performed on a VG ZAB HF mass spectrometer 
usmg negative ion desorption [24,25]. The samples were dissolved in 
acetic acid/methanol 1: 1 (v/v) to a concentration of about 5 &ml and 
applied to the target coated with triethanolamme as matrix. The reso- 
lution of the instrument was set to 500 ppm and the sample was 
bombarded with xenon atoms with a kinetic energy equivalent to 9 kV. 
Spectra were recorded with an AMD-Intectra data system. 
3. RESULTS 
The gangliosides of 2dGal-treated rat livers were pu- 
rified and isolated by alkaline methanolysis and differ- 
ent chromatographic procedures as described in section 
2. After final separation by HPLC, the purity of the 
different isolated gangliosides was examined by 
HPTLC, as shown in Fig. 1. The amounts of isolated 
gangliosides are summarized in Table I. All isolated 
gangliosides contained negligible quantities of impuri- 
ties. 
In order to analyse the composition of the oligosac- 
charide moieties of the isolated gangliosides, samples 
were submitted to hydrolysis as described above. Data 
GM3 - 
GM2 - 
GM1 - 
Ea 1 
GDlb _ 
Start - 
ST GTlb GDlb GW GM3 
Fig. 1. Purity of the isolated gangliosides G,,, Gb3. G,,, and GTlb 
after separation by HPLC. Gangliosides were purified by HPLC as 
described. After purification the samples were dissolved in chloro- 
form/methanol (1:l; v/v). 5% of each ganglioside was applied to the 
HPTLC plate and separated m chloroform/methanol/0.2% aqueous 
CaCI, (50:45.10: by vol.) Finally. the chromatogram was stained with 
copper sulfate reagent, 10 pg of bovine brain gangliosides serve as a 
standard (ST). 
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Table I 
Amounts of isolated gangliosides after separatton by HPLC and the 
rate of exchange of o-galactose against 2-deoxy-o-galactose 
Purified gangliostde Amount of Isolated Exchange rate 
gangliostde (nmol/g (o-galactose/ 
liver wet weight) 2-deoxy-o-galactose) 
G M3 63 28% (40%)” 
G DZ 0.6 56% 
G Dlb 2.0 traces only 
G 71h 0.2 > 10% 
*Value obtained from the sum of relative intensittes of molecular tons 
produced by the 2-deoxy-o-galactose-containing G,, tsospectes by 
FAB/MS analysts. 
from GLC/MS analysis show clearly that 2dGal is in- 
corporated into every ganglioside investigated. for ex- 
ample into G,, as shown in Fig. 2, but in different 
amounts, as shown in Table I. The gas chromatogram 
of the hydrolysed and peracetylated sample. Fig. 2B. 
shows a peak (2) which co-chromatographs with the 
peracetylated 2dGal. Under electric ionization condi- 
tions the fragmentation pattern of this peak resembles 
the peracetylated standard. Clearly detectable are the 
primary fragment ions at m/z 145, 159 and 231. As a 
secondary fragment the [M+ l-601 molecular ion, after 
elimination of acetic acid, is detectable at m/z 3 17. The 
epimer, 2-deoxy-D-glucose, was not detected in any gan- 
glioside. 
The negative ion mass spectrum of the G,, fraction 
derived from 2dGal-modified rat liver gangliosides is 
shown in Fig. 3 [24]. Major fragment ions are observed 
for the ceramide moiety at m/z 536 (palmitoylsphingo- 
sine) and at m/z 646 and 648 (nor marked) with CZ4, and 
C 14 0 fatty acids. The corresponding ions for the 
monohexosylceramides are observed at m/z 698, 808, 
810 (not marked) and at m/z 860,970,972 (not marked) 
for the dihexosylceramide ions, respectively. All these 
ions represent G,, fragments that do not contain 
2dGal. Among the more intense molecular ions [M-l]- 
that are shown in the insert, two series of ions can be 
clearly recognized. They may be attributed to G,,, iso- 
species (Table IT) carrying C,,-C,, fatty acids and con- 
taining either two hexoses or one hexose and one de- 
oxyhexose. The ions derived from deoxy galactose-con- 
taining species appear at 16 a.m.u. lower mass values. 
Isospecies with Cz,,.o. C,,, and C,,, fatty acids in the 
ceramide portion consistently showed higher relative 
intensities for the deoxy compound. 
The FAB/MS analysis of the G,,, fraction was per- 
formed on a very small amount (1 pug). Therefore, only 
molecular ions were observed, the major ones at m/z 
1,907 [M+2Na+-3]- and 1,885 [M+Na’-2]- pointing to 
the presence of a C,, ceramide with either C,, fatty acid 
and sphingosine or C,, fatty acid and eicosasphingo- 
sine. The presence of ions of lower intensity at m/z 1,89 1 
and 1,869 point to a partial incorporation of at least one 
deoxy-galactose into the G,,, fraction. 
4. DISCUSSION 
This is the first report of the incorporation of the 
hexose analogue. 2-deoxy-D-galactose (2dGal), into the 
oligosaccharide moieties of different gangliosides. In 
20 25 30 
Time [mln] 
20 25 30 35 
Time [min] 
160 150 258 388 358 
m/e 
Ftg. 2. Gas chromatography/mass spectrometry analysis of liver gan- 
glioside G,,, from rats treated wtth 2dGal. The htghly purified gangh- 
oside was subjected to a mild actdrc hydrolysis and the released mon- 
osaccharides were subsequently reduced and peracetylated as de- 
scrtbed. Peracetylated derivattves of aldttols were analysed by GC. (A) 
Standrd mixture of peracetylated dertvatives from left to right: 2- 
deoxy-o-ribitol. o-ribno), L-fucttol, o-xyhto). 2-deoxy-o-glucttol (I), 
2-deoxy-o-galactitol (2). inosttol (internal standard, 3). o-mannitol. 
o-g)ucitol (4). o-galactito) (5). 2-acetamido-2-deoxy-n-glucitol. 2-Xet- 
amide-2-deoxy-o-manmtol and 2-acetamido-2-deowy-o-galactitol. 
For G,, expected peracetylated aldttols are numbered. (B) GC of 
sample G,,. (C) GC/mass spectrum [M+l-601 from (3) under EI 
condtttons. 
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Fig. 3. Negative ion FAB mass spectrum of the G,, fractton contammg isospecles with 2dGal. The attributron of the molecular ions [M-l]- shown 
in the insert is presented in Table II. The oligosaccharide moiety of the new ganghostde. ZdGal-modified G,,, is composed of o-glucose, 2dGal 
and N-acetyl-neuraminic acid. We suggest he possible substitution of the g&lactose residue by a 2dGal residue as shown 
earlier studies we used different approaches to demon- 
strate that 2dGal is incorporated into the oligosac- 
charide moiety of membrane giycoproteins [2,3]. These 
findings are in agreement with data on the metabolism 
of 2dGa1, which indicated the formation of UDP-2- 
deoxy-D-galactose. Since UDP-o-galactose:giucosylcer- 
amide galactosyltransferase, which transfers activated 
o-galactose, is not absolutely specific for its substrate 
1261, it is reasonable to suppose that it can also transfer 
UDP-2dGal to gangliosides. 
After the administration of 2dGal to rats, this hexose 
analogue was detected in all of the investigated gangli- 
Table II 
Molecular ions [M-l]- and fragment ions observed in the negative ran FAB mass spectrum of the G,, fraction (Fig. 3) contaming C,bC24 fatty 
acids and either galactose or 2-deoxy galactose (deoxy-G,,) 
Fatty acid of 
ceramide 
Cer 
Fragment ions 
Glc-Cer Gal-Glc-Cer” 
Molecular ions [M-l]- 
G M? Deoxy-G,, 
CM 536 698 860 1.151 1,135 
C,, 1.179 1,163” 
CZ” 1,207 I.191 
C*z 1,235 1,219 
C?4 I
C,, 646 808 970 
1,261 1 .245b 
64@ 810b 97P 
1 .263b 1,247 
a Minor fragment ions not surpassing the noise level ‘-fold were not marked. 
bNot marked in Fig. 3. 
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osides of rat liver. It should be noted that the difference 
of incorporated 2dGal into G,, between GLC/MS and 
FAB/MS data may be due to the hydrolysation condi- 
tions prior to GLC/MS analysis. As a proportion of the 
replaceable galactose residues, the replacement was es- 
pecially pronounced in G,, and Go,. 
At least three reasons may account for these findings. 
First, the turnover of the G,, and Go, pool is higher 
than that of the other gangliosides. Second, lactosylcer- 
amide is formed on the cytoplasmic side of the cis-Golgi 
leaflet [lo-121; for all the other steps of glycosylation, 
UDP-D-galactose or UDP-2dGal must be transported 
into the Golgi apparatus by specific transporters [26]. 
This is in accordance with recent findings on 2dGal 
incorporation into membrane glycoproteins of our 
group [3]. In the study, we have shown that only 10% 
of the galactose residues of glycoproteins were replaced 
by 2dGal. No data are available on the selectivity of this 
transporter for 2dGal. Third, the mild hydrolytic condi- 
tions cleave predominantly terminal or subterminal 
2dGal residues; 2dGal residues incorporated into higher 
gangliosides may not be accessible to this treatment. 
Finally, further studies are needed to confirm the 
proposed structures of the 2dGal-modified gangli- 
osides, for example nuclear magnetic resonance (NMR) 
analysis. Such studies would require the isolation of 
larger amounts of modified gangliosides. In addition it 
would be interesting to examine the effects of 2dGal- 
modified gangliosides on ganglioside metabolism in 
general. 
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